Detalhe da pesquisa
1.
Hyperkalaemia in Cardiological Patients: New Solutions for an Old Problem.
Cardiovasc Drugs Ther
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289453
2.
Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes.
Heart Fail Rev
; 28(3): 723-732, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098383
3.
Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?
Int J Mol Sci
; 24(12)2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373108
4.
Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.
Heart Fail Rev
; 27(3): 767-778, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382883
5.
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study.
Europace
; 24(2): 234-244, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34392336
6.
Mechanisms of action of SGLT2 inhibitors and their beneficial effects on the cardiorenal axis.
Can J Physiol Pharmacol
; 100(2): 93-106, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112597
7.
ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.
Eur Heart J Suppl
; 24(Suppl C): C272-C277, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35602255
8.
The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney.
Int J Mol Sci
; 23(19)2022 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233288
9.
Recent advances in pharmacological treatment of heart failure.
Eur J Clin Invest
; 51(11): e13624, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043809
10.
ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes.
Eur Heart J Suppl
; 23(Suppl C): C184-C195, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34456645
11.
Current challenges in sudden cardiac death prevention.
Heart Fail Rev
; 25(1): 99-106, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346843
12.
Risk of heart failure progression in patients with reduced ejection fraction: mechanisms and therapeutic options.
Heart Fail Rev
; 25(2): 295-303, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410756
13.
CardioMEMS, the real progress in heart failure home monitoring.
Heart Fail Rev
; 25(1): 93-98, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512148
14.
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction.
Eur Heart J Suppl
; 22(Suppl L): L77-L81, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33727901
15.
Letter by Gronda et al Regarding Article, "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial".
Circulation
; 145(16): e839-e840, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436134
16.
Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study.
J Card Fail
; 23(9): 702-707, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645757
17.
Glucagon and heart in type 2 diabetes: new perspectives.
Cardiovasc Diabetol
; 15(1): 123, 2016 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27568179
18.
Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Curr Heart Fail Rep
; 13(6): 273-280, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27854009
19.
Novel approaches to the post-myocardial infarction/heart failure neural remodeling.
Heart Fail Rev
; 19(5): 611-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24292688
20.
Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest.
J Clin Med
; 12(2)2023 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675622